Clinical and experimental studies indicate that increased oxidative stress in HIV infection, sometimes exacerbated by some antiretroviral drugs, is associated with a reduction in CD4+ T-cell level, cytotoxicity, and endothelial dysfunction, contributing to atherosclerotic changes [30]. Here, CD4 is linked to endothelial dysfunction.